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Serum levels and prescribed dosages of vitamin A and E in patients 
with cystic fibrosis 
E. Karlge Nilsson, B. Str andvik, E. Gr onowit z, A. Lindblad 
Dept of Pediatrics, West Swedish CF Centre, GStebor~ University, Sweden. 
The a im of the study was to evaluate the serum levels of vitamin A and E, and 
compare those to prescribed oses and to normal serum levels in comparison to the 
recommendations given in the consensus report (1) 
Mater ia l :  One hundred twelve consecutive patients, (males 64 ) attending the 
annual checkup at the West Swedish CF Centre ha 2CO3 were included. Patients 
diaguosed less than a year before the annual review, preguant, transplanted or 
patients wait ing for transplantation were excluded. Ninety two (82%) were 
pancreatic insufficient (PI). Mean age were 20.4+ 12.0 years; 48% were >18 years. 
Method: Serum levels of alpha tccopherol and rethaol were measured in the 
morning after one night fast. Mean+SD are given. 
Results: S~etinol were 2.2+0.6~tmo1/1 Patients with PI had significantly lower s 
retinol than patients with PS (p~).03), without difference between adults mad 
children. Al l  but one patient had s retinol levels within the reference range. There 
was no cotlelation between s~etinol levels mad FEV 10 or age Prescribed amount of 
vitamin A were 4480 + 2528 IU (range 2@ 15900 IU) ha patients with PI and PS. 
S alpha4ccopherol was 26.2 + 11 .l~tmol/l. Seven patients (all PI) had serum levels 
below the reference range. There was no correlation between s o:4ccopherol and 
FEVI0, PI/PS or age Prescribed amount of vitamin E was 260 + 138 IU ha the PI 
group and 81 + 94 IU in the PS group. 
Conclus ion:  The supplementat ion of v i tamin A mad E were  wi th in  the 
recommendations and most patients had serum concentrations within the reference 
range. Low adherence could be one explanation to low serum levels of t ccopher ol 
in some patients despite the prescribed E vitamin dosage. 
1. Sinaasappel M et al. J Oyst Fibr 2C02;1:51 75 
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Vitamin D status in children with Cystic Fibrosis 
H. Creedon, D Urquhar t, A. Jaffe 
Paediatric Cystic Fibrosis Unit, Great Ormo~ul Street Hospital, London, Englmul 
Background:  Bone disease and low bone mineral density are recoguised as long 
term complications in the adolescent and adult fi~stic Fibrosis (CF) population. 
Sub optimal levels of serum 25 OH Vitamin D (25 OHD) have been reported in the 
CF literature and may contribute to poor bone mineral density. Levels <25nmol/l are 
classed as deficient, however ecent CF literature has suggested that serum 25 OHD 
levels should be maintained at 75 nmol/ l  150 nmol/ l  to improve bone accretion. In 
our clinic all pancreatic insnfBcient children are prescribed a daily Vitamin D 
supplement of either 10 pg or 15 btg for infants and individuals > 1 year of age 
respectively. We aimed to determine the prevalence of Vitamin D deficiency in our 
CF population. Methods:  The serum 25 OHD level of children attending the CF 
annual review were measured. Data were analysed according to age (0 5 years, 5 
10 years mad 10 16 years) and whether the serum 25 OHD levels were measured in 
winter, spring, s~ammer or autumn months. Results: 187 children (aged 0 16 years) 
were studied. The mean (+SD) serum 25 OHD level was 48.30 (18.03) nmol/l ,  
range (21 125 nmol/l). Three percent had levels less than 25 nmol/ l  mad 6% had 
levels > 75nmol/l.  The mean serum 25 OHD in the summer months, 66.41(17.80) 
nmol/l ,  was significantly higher (p<0.CO1) than those measured uring the rest of 
the year, winter 42.80 (14.90) nmol/l ,  spring 40.60 (12.69) nmol/ l)  and autumn 
51 .CO (16.54) nmol/l .  This effect was independent of age. Conclusion: The majority 
of chi ldren were found to have 25 OHD levels > 25 nmol/ l  but < 75 nmol/l .  To 
maintain serum 25 OHD levels consistently > 75 nmol/ l  our current Vitamin D 
supplementation regimen may not be adequate. Further esearch regarding optimal 
25 OHD levels mad adequate Vitamin D dosage to support his is needed. 
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An audit of addi~onal vitamin D supplementation on vitamin D levels 
in children with cystic fibrosis 
S.P. Wolfe, K.G. Br ownlee, C. Silburn, S.P. Conway 
Regional Paediatric CF Unit, St James' University Hospital, Leeds, UK 
In t roduct ion There is increasing evidence that vitamin D deficiency mad seasonal 
variability in plasma levels may predispose to the development of osteoporosis. 
Vitamin D is usually given ha combination with vitamin A. Increasing the dose may 
lead to vitamin A toxicity and a separate vitamin D preparation may be required. We 
report he change ha vitamin D levels over 4 years fol lowing the implementation of 
a vitamin D supplementation protocol. 
Method 104 children, median age 7.3yrs (0.3 13.2) had plasma 25 hydr oxy vitamin 
D levels measured ha 2CO0. A l l  were receiving 10~i0 ~tg vitamin D combined with 
vitamin A. I f  the vitamin D level was below 30 ng/ml patients received a review of 
vitamin and pancreatic enzyme dosing and adherence. Additional s~applement ation 
with a preparation containing calcium and vitamin D (10 30 ~tg/d) was given as 
appropriate. Levels were reassessed in 2CO4. 
Results The mean (SD) vitamin D levels for 2CO) and 2CO4 were 19.5 ng/ml (7.5) 
and 25.3 ng/ml (7.5) respectively (p<0.CO1). The proportion of patients above 20 
ng/ml and 30 ng/ml increased from 45% to 71% mad 8% to 19% respectively. The 
percentage of patients in each season within a range of serum vitamin D values is 
shown below: 
Season Jan Mal Apr Jtm July Sept Oct Dec 
ng/ml 2000 2004 2000 2004 2000 2004 2000 2004 
< 10 38 0 5 0 0 0 4 11 
10 90 69 99 51 0 37 6 46 94 
?0 30 0 63 35 63 48 61 46 61 
> 30 0 6 8 35 15 33 4 5 
Discussion These results confirm a seasonal variation ha vitamin D levels and 
demonstrate hat a protc¢ol aimed at increasing levels has resulted ha a significant 
improvement. However, 94.5% of children in the winter months till had levels less 
than 30 ng/ml. This suggests that some patients need more vitamin D than is 
currently recommended in nutritional guidelines. 
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Somatic development of CF children diagnosed in neonatal screening 
D. Sands, A. Nowakowska, R. Piotr owski, M. Mielus, K. Walicka, A. Mi lanowski  
CF Center Warsaw, Polmul 
The a im of our study was to assess the nutritional status of chi ldren diaguosed in 
neonatal screening from 1999 2CO3. 
Among 71 children diagnosed, 57 (27 girls, 30 boys) born in 1999 2003 are 
followed up in the Warsaw CF Center. 
The children were subdivided into 2 groups: 
1. Pilot group 11 children born in 1999. Mean age of dia~aosis was 15 weeks. 
2. Ma in  group ~,6  children born in 2000 2CO3. Mean age of CF diagnosis was 6 
weeks. 
Al l  patients had regular weight and height measurements. 
49 newboms were full term with mean birth weight (kg) female 3,161 (SD 0,44) and 
male 3,46 (SD 0,45) 
8 premature babies with mean birth weight (kg) female 2,63 (SD 0,35) ,  male 2,19 
(SD 0,6) 
In 55 chi ldren PI was diaguosed. They were given pmacreatic enzymes. 
Only 2 chi ldren from the main group were PS (A F508/3849+10kbCT, A F508/?) 
with normal somatic development and normal elastase 1 ha stool. 
Somatic development was normal in 63% of chi ldren from the main group and 46% 
of the pilot group; dysharmonic ha 22% of the main group mad 35 % of the pilot 
group; abnormal ha 15 % of the main group and 19% of the pilot group. 
The biggest changes ha nutritional status were observed in the first year of life, 
especially in the pilot group. Subsequently nutritional status was gradually 
improving. At  the end of the 4 ~ year of l ife 100% of chi ldren from the main group 
had normal nutritional status compared to 80% from the pilot group. 
Condusioz~s: 
1. The mean birth weight of CF children from neonatal screening was not lower than 
mean birth weight of Polish healthy newborns. 
2. Most infants presented clinical symptoms of pancreatic insufficiency 
Early introduction of complex therapy including nutrit ional treatment with 
pancreatic enzymes mad electrolytes supplements prevents evere malnutrition. 
